Skip to main navigation

News & Events Publications Patient Resources Contact
  • About Us
    • Leadership
    • Board
    • Scientific Advisors
    • Careers & Culture
    • Open Opportunities
  • Science
    • HBV Assets
      • Imdusiran (AB-729)
      • AB-101
  • Pipeline
  • Partnering
  • >
  • Investors
    • Investor Center
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Investor FAQ
    • Contact Us
  • Culture & Careers

Investor Relations

  • Investor Center
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Press Releases
  • Events & Presentations
  • Investor FAQ
  • Contact Us

SEC Filing Details

Document Details

Form
144
Filing Date
Feb 4, 2025
Document Date
Feb 4, 2025
Form Description
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing
Filing Group
Other
Company
Arbutus Biopharma Corporation
Issuer
ARBUTUS BIOPHARMA CORP

Filing Formats

View HTML
Download PDF
Download DOC

Shareholder Tools

  • Email Alerts Email Alerts
  • RSS News Feeds RSS News Feeds
  • Download Library Download Library

© 2026 Arbutus Biopharma

Legal Terms